Please note most of these publications were published by our predecessor company CellPoint, LLC.

CENTENNIAL, Colo., February 10, 2010

Cell>Point announced today that M. Donald Blaufox, M.D., Ph.D, will be coordinating principal investigator for its Phase 2/3 clinical trial of99mTc-EC-G for cancer diagnostic imaging. The trial is currently underway.